REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 98 filers reported holding REPROS THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $13,672,000 | -2.6% | 790,264 | -0.1% | 0.01% | 0.0% |
| Q1 2014 | $14,033,000 | +1.6% | 791,064 | +4.8% | 0.01% | 0.0% |
| Q4 2013 | $13,807,000 | +1.2% | 754,477 | +48.2% | 0.01% | -7.1% |
| Q3 2013 | $13,643,000 | +16.8% | 509,073 | -19.6% | 0.01% | +16.7% |
| Q2 2013 | $11,676,000 | – | 632,872 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $11,290,000 | 4.00% |
| SENZAR ASSET MANAGEMENT, LLC | 764,406 | $7,621,000 | 2.23% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $3,280,000 | 0.88% |
| RTW INVESTMENTS, LP | 229,364 | $2,287,000 | 0.85% |
| CQS Cayman LP | 700,000 | $6,979,000 | 0.46% |
| GENERAL AMERICAN INVESTORS CO INC | 508,375 | $5,068,000 | 0.40% |
| Alden Global Capital Ltd | 154,000 | $1,535,000 | 0.37% |
| J. Goldman & Co LP | 197,500 | $1,969,000 | 0.23% |
| Baker Brothers Advisors | 2,000,000 | $19,940,000 | 0.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $997,000 | 0.17% |